Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma.
dc.contributor.author | Carrera, Caty | |
dc.contributor.author | Cárcel-Márquez, Jara | |
dc.contributor.author | Cullell, Natalia | |
dc.contributor.author | Torres-Águila, Nuria | |
dc.contributor.author | Muiño, Elena | |
dc.contributor.author | Castillo, José | |
dc.contributor.author | Sobrino, Tomás | |
dc.contributor.author | Campos, Francisco | |
dc.contributor.author | Rodríguez-Castro, Emilio | |
dc.contributor.author | Llucià-Carol, Laia | |
dc.contributor.author | Millán, Mònica | |
dc.contributor.author | Muñoz-Narbona, Lucía | |
dc.contributor.author | López-Cancio, Elena | |
dc.contributor.author | Bustamante, Alejandro | |
dc.contributor.author | Ribó, Marc | |
dc.contributor.author | Álvarez-Sabín, José | |
dc.contributor.author | Jiménez-Conde, Jordi | |
dc.contributor.author | Roquer, Jaume | |
dc.contributor.author | Giralt-Steinhauer, Eva | |
dc.contributor.author | Soriano-Tárraga, Carolina | |
dc.contributor.author | Mola-Caminal, Marina | |
dc.contributor.author | Vives-Bauza, Cristófol | |
dc.contributor.author | Navarro, Rosa Díaz | |
dc.contributor.author | Tur, Silvia | |
dc.contributor.author | Obach, Victor | |
dc.contributor.author | Arenillas, Juan Francisco | |
dc.contributor.author | Segura, Tomás | |
dc.contributor.author | Serrano-Heras, Gemma | |
dc.contributor.author | Martí-Fàbregas, Joan | |
dc.contributor.author | Delgado-Mederos, Raquel | |
dc.contributor.author | Freijo-Guerrero, M Mar | |
dc.contributor.author | Moniche, Francisco | |
dc.contributor.author | Cabezas, Juan Antonio | |
dc.contributor.author | Castellanos, Mar | |
dc.contributor.author | Gallego-Fabrega, Cristina | |
dc.contributor.author | González-Sanchez, Jonathan | |
dc.contributor.author | Krupinsky, Jurek | |
dc.contributor.author | Strbian, Daniel | |
dc.contributor.author | Tatlisumak, Turgut | |
dc.contributor.author | Thijs, Vincent | |
dc.contributor.author | Lemmens, Robin | |
dc.contributor.author | Slowik, Agnieszka | |
dc.contributor.author | Pera, Johanna | |
dc.contributor.author | Kittner, Steven | |
dc.contributor.author | Cole, John | |
dc.contributor.author | Heitsch, Laura | |
dc.contributor.author | Ibañez, Laura | |
dc.contributor.author | Cruchaga, Carlos | |
dc.contributor.author | Lee, Jin-Moo | |
dc.contributor.author | Montaner, Joan | |
dc.contributor.author | Fernández-Cadenas, Israel | |
dc.date.accessioned | 2025-01-07T16:18:12Z | |
dc.date.available | 2025-01-07T16:18:12Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Haemorrhagic transformation is a complication of recombinant tissue-plasminogen activator treatment. The most severe form, parenchymal haematoma, can result in neurological deterioration, disability, and death. Our objective was to identify single nucleotide variations associated with a risk of parenchymal haematoma following thrombolytic therapy in patients with acute ischaemic stroke. A fixed-effect genome-wide meta-analysis was performed combining two-stage genome-wide association studies (n = 1904). The discovery stage (three cohorts) comprised 1324 ischaemic stroke individuals, 5.4% of whom had a parenchymal haematoma. Genetic variants yielding a P-value | |
dc.identifier.doi | 10.1093/brain/awab090 | |
dc.identifier.essn | 1460-2156 | |
dc.identifier.pmc | PMC8418348 | |
dc.identifier.pmid | 33723576 | |
dc.identifier.pubmedURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC8418348/pdf | |
dc.identifier.unpaywallURL | https://academic.oup.com/brain/article-pdf/144/8/2416/40305952/awab090.pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27741 | |
dc.issue.number | 8 | |
dc.journal.title | Brain : a journal of neurology | |
dc.journal.titleabbreviation | Brain | |
dc.language.iso | en | |
dc.organization | Instituto de Investigación Biomédica de Sevilla (IBIS) | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | 2416-2426 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, N.I.H., Extramural | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights.accessRights | open access | |
dc.subject | GWAS | |
dc.subject | ischaemic stroke | |
dc.subject | parenchymal haematoma | |
dc.subject | pharmacogenetics | |
dc.subject | thrombolysis | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Cerebral Hemorrhage | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fibrinolytic Agents | |
dc.subject.mesh | Genome-Wide Association Study | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Ischemic Stroke | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Polymorphism, Single Nucleotide | |
dc.subject.mesh | Thrombolytic Therapy | |
dc.subject.mesh | Tissue Plasminogen Activator | |
dc.subject.mesh | Transcription Factors | |
dc.subject.mesh | Treatment Outcome | |
dc.title | Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 144 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- PMC8418348.pdf
- Size:
- 483.31 KB
- Format:
- Adobe Portable Document Format